Global In-vitro Fertilization (IVF) Devices Market 2015-2019
Globally one in six couples face infertility issues. IVF is one of the popular treatments that has benefitted childless couples, single mothers, and LGBT community. It involves specific and complicated procedures with mixed proportion of both success and failure. According to CDC, nearly 1.5 million cycles of IVF is performed worldwide every year, and about 55 percent of the reported cycles are carried out in Europe. The Global IVF Devices market is growing at high pace, promising high return on investment.
TechNavio’s analysts forecast the Global IVF Devices market to grow at a CAGR of 10.80 percent over the period 2014-2019.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global IVF Devices market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the following IVF devices based on the type of products, namely:
- IVF Disposable Devices
- Culture Media
- Capital Equipment
The scope does not include hormones, pharmaceuticals, clinicians and medical professionals’ fees, laboratory charges, or other medication or treatment charges.
TechNavio’s report, Global IVF Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global IVF Devices market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key Regions
- Americas
- APAC
- EMEA
Key Vendors
- Cook Medical
- Cooper Surgical
- Irvine Scientific Sales
- Vitrolife
Other Prominent Vendors
- Auxogyn
- Cell Cura
- EMD Serono
- Fertility Focus
- IKS International
- In Vitro Care
- INVO Bioscience
- IVFtech Aps
- Kitazato
- Life Global
- Meditex
- Microtech IVF s.r.o
- Nidacon International
- NuSep
- Ovascience
- Pantec Biosolutions
- Reproductive Health Science
- ReproTech
- Smiths Medicals International
- Sperm Processor
- Xytexcryp International
Market Driver
- Increase in IVF Success Rate
- For a full, detailed list, view our report
Market Challenge
- High Cost of IVF Procedures
- For a full, detailed list, view our report
Market Trend
- Increase in Number of Fertility Clinics
- For a full, detailed list, view our report
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Table of Contents
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Overview
06.1.1 Epidemiology of Infertility
07. Market Landscape
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Market Segmentation by Category
07.4 Five Forces Analysis
08. Regulatory landscape of ART and IVF
08.1.1 Reporting Requirements
08.1.2 IVF Procedure Regulations
08.1.3 Need for More Guidance and Regulations
09. Fertility Tourism
10. Cost Analysis of IVF Treatment:
11. Geographical Segmentation
11.1 IVF Devices Market in the Americas
11.1.1 Market Size and Forecast
11.2 IVF Devices Market in the EMEA Region
11.2.1 Market Size and Forecast
11.3 IVF Devices Market in the APAC Region
11.3.1 Market Size and Forecast
12. Key Focus Countries
12.1.1 Belgium
12.1.2 China
12.1.3 India
12.1.4 Israel
13. Reimbursement Scenario
14. Buying Criteria
15. Market Growth Drivers
16. Drivers and their Impact
17. Market Challenges
18. Impact of Drivers and Challenges
19. Market Trends
20. Trends and their Impact
21. Vendor Landscape
21.1 Competitive Scenario
21.1.1 Key News
21.1.2 Mergers and Acquisitions
21.2 Key Vendors in Global IVF Devices Market are listed below:
21.3 Other Prominent Vendors
22. Key Vendor Analysis
22.1 Cook Medical
22.1.1 Key Facts
22.1.2 Business Overview
22.1.3 Key Divisions
22.1.4 Geographical Segmentation 2013
22.1.5 Business Strategy
22.1.6 Recent Developments
22.1.7 SWOT Analysis
22.2 CooperSurgical
22.2.1 Key Facts
22.2.2 Business Description
22.2.3 Business Segmentation
22.2.4 Business Segmentation by Revenue
22.2.5 Business Segmentation by Revenue 2012 and 2013
22.2.6 Business Strategy
22.2.7 Key Developments
22.2.8 SWOT Analysis
22.2.9 Strengths
22.2.10 Weaknesses
22.2.11 Opportunities
22.2.12 Threats
22.3 Irvine Scientific
22.3.1 Key Facts
22.3.2 Business Overview
22.3.3 Recent Developments
22.3.4 SWOT Analysis
22.4 Vitrolife
22.4.1 Key Facts
22.4.2 Business Overview
22.4.3 Geographical Segmentation by Revenue 2013
22.4.4 Business Strategy
22.4.5 Recent Developments
22.4.6 SWOT Analysis
23. Other Reports in this Series
List of Exhibits:
Exhibit 1: Market Research Methodology
Exhibit 2: Infertility Statistics in US 2010 by Gender
Exhibit 3: Infertility Statistics in the US, a comparison from 2002-2010 by age (15-44)
Exhibit 4: Segmentation of Infertility Statistics in US, a comparison from 2002 to 2010 by Cause
Exhibit 5: Global IVF Market 2014-2019 (US$ million)
Exhibit 6: Global IVF Market by Category Segmentation 2014
Exhibit 7: Global Hubs for Fertility Tourism
Exhibit 8: Average cost of IVF during Hormonal Stimulation stage in US$ by Age of Patients
Exhibit 9: Cost Analysis of IVF Treatment by various stages involved
Exhibit 10: Global IVF Devices Market by Geographical Segmentation 2014
Exhibit 11: Global IVF Devices Market by Geographical Segmentation 2014-2019 (in percent)
Exhibit 12: IVF Devices Market in Americas Region 2014-2019 (US$ million)
Exhibit 13: IVF Devices Market in EMEA Region 2014-2019 (US$ million)
Exhibit 14: IVF Devices Market in APAC Region 2014-2019 (US$ million)
Exhibit 15: Snapshot of Key Countries in Global IVF Devices Market 2014
Exhibit 16: Patients Travelling to Belgium for IVF Treatment by Nationality, 2014
Exhibit 17: Worldwide IVF Success Rates Using Non-donor Eggs by Age
Exhibit 18: Vitrolife: Geographical Segmentation by Revenue 2013
Exhibit 19: CooperSurgical: Business Segmentation 2013
Exhibit 20: CooperSurgical: Business Segmentation by Revenue 2013
Exhibit 21: CooperSurgical: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 22: Cook Medical: Key Divisions
Exhibit 23: Cook Medical: Geographical Segmentation 2013